SPY
777.05
−0.02%
QQQ
757.75
+0.00%
BTC/USD
83,335.11
−2.59%
DIA
510.78
−0.05%
GLD
376.63
+0.20%
TLT
77.09
−0.07%
US
Sign in
Register
My Account
Benzinga
Markets & News
Markets
Stocks & Sectors
Stocks
Ratings & Research
Ratings
Trading
Trading
Screeners & Lists
Screeners
Learn
Learn
Premium
Premium Services
Markets & News
Breaking headlines, the trading day, and the calendars that move it.
Stocks & Sectors
Research any ticker, then drill into sectors, ratings, and options.
Ratings & Research
Wall Street calls, insider moves, and Benzinga's own stock rankings.
Trading
Options flow, trade calculators, and ideas for active traders.
Screeners & Lists
Filter the market your way, or start from a curated list.
Learn
Pick a broker, grow your savings, and protect what you've built.
Premium Services
Edge
Ratings, signals & screens
Pro
Real-time news & data terminal
Research
Trade alerts & newsletters
APIs
Market data licensing
All sections
Ardelyx Inc
ARDX
NASDAQ
Watchlist
Get Report
Trade with Public
Get Report
Trade with Public
$3.26
-0.05
-1.51%
Last update: Oct 7, 4:02 PM
$3.26
-0.05
-1.51%
Get Report
Overview
News
Events
Financials
Sentiment
Ownership
Compare
Options
Stock Report
Privacy Manager
My Account
My Account
Notifications
Overview
+ New Watchlist
Benzinga
Edge
Benzinga
Research
Benzinga
Pro
Logout
Ardelyx Analyst Price Targets - Benzinga
Ardelyx Analyst Price Targets
Wall Street analyst price targets and consensus rating for Ardelyx (ARDX).
Analyst Ratings News
PRO
Wedbush Reiterates Outperform on Ardelyx, Maintains $9 Price Target
Wedbush analyst Laura Chico reiterates Ardelyx (NASDAQ:ARDX) with a Outperform and maintains $9 price target.
Benzinga Newsdesk
PRO
Wedbush Reiterates Outperform on Ardelyx, Maintains $9 Price Target
Wedbush analyst Laura Chico reiterates Ardelyx (NASDAQ:ARDX) with a Outperform and maintains $9 price target.
Benzinga Newsdesk
PRO
Piper Sandler Maintains Overweight on Ardelyx, Lowers Price Target to $15
Piper Sandler analyst Christopher Raymond maintains Ardelyx (NASDAQ:ARDX) with a Overweight and lowers the price target from $16 to $15.
Benzinga Newsdesk
PRO
Citigroup Maintains Buy on Ardelyx, Lowers Price Target to $11
Citigroup analyst Yigal Nochomovitz maintains Ardelyx (NASDAQ:ARDX) with a Buy and lowers the price target from $14 to $11.
Benzinga Newsdesk
PRO
TD Cowen Maintains Buy on Ardelyx, Lowers Price Target to $10
TD Cowen analyst Joseph Thome maintains Ardelyx (NASDAQ:ARDX) with a Buy and lowers the price target from $13 to $10.
Benzinga Newsdesk
PRO
BTIG Maintains Buy on Ardelyx, Lowers Price Target to $14
BTIG analyst Julian Harrison maintains Ardelyx (NASDAQ:ARDX) with a Buy and lowers the price target from $17 to $14.
Benzinga Newsdesk
Create a Watchlist
FREE: Follow your stocks and cryptocurrencies with the most actionable alerts on the internet.
Click to Get Started
People Also Watch
AbbVie Inc
NYSE:ABBV
$271.76
0.15%
Amgen Inc
NASDAQ:AMGN
$413.08
-%
Gilead Sciences Inc
NASDAQ:GILD
$146.85
-%
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
$505.64
-%
Moderna Inc
NASDAQ:MRNA
$196
-0.24%
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
$742.12
-%
argenx SE
NASDAQ:ARGX
$928.44
-%
Natera Inc
NASDAQ:NTRA
$395.56
-%
Revolution Medicines Inc
NASDAQ:RVMD
$200.87
-%
BeOne Medicines Ltd
NASDAQ:ONC
$360.4
-1%
Show all 10 related companies
